Induction of lymphohematopoietic chimerism through bone marrow transplantation (BMT) can lead to life-long transplantation tolerance without the need for chronic immunosuppression. However, BMT across major histocompatibility (MHC) barriers is severely limited by problems associated with the severity of the host preparative regimen required, the potential for lethal graft-versus-host disease (GVHD), and engraftment failure. These problems could potentially be avoided by using a gene therapy approach to introduce allogeneic MHC genes into autologous bone marrow rather than transferring immunocompetent cells into the host. Using retroviral gene therapy, the allogeneic MHC class I gene H-2Kb (Kb) has been introduced into syngeneic bone marrow. Reconstitution of lethally irradiated syngeneic mice with bone marrow transduced with the Kb gene has been found to produce the specific prolongation of Kb bearing skin allograft survival. The major goals of this proposal are to examine the mechanism(s) by which expression of the transduced allogeneic MHC gene in BM derived cells lead to prolonged survival of Kb disparate skin grafts, and to establish conditions permitting long-term expression of the transduced gene in BM derived cells for the purpose of inducing life-long allograft acceptance.
The specific aims are to: 1) Establish conditions permitting long-term expression of the retrovirally transduced H-2Kb gene in bone marrow derived cells; 2) Determine the mechanism by which expression of the transduced MHC class I gene product affects reactivity of anti-Kb CD8 T cells. 3) Determine the mechanism by which expression of retrovirally transduced Kb in bone marrow derived cells affects the ability of CD4 T cells to respond Kb disparate targets; and, 4) Evaluate the ability of Kb expressing cells of various lineages to induce specific prolongation of Kb disparate skin graft survival. These studies should provide practical information important for the field of transplantation on the mechanism of tolerance induced by gene therapy, and should also provide theoretical insights which may advance our understanding of self-nonself discrimination with respect to MHC antigens.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI043619-02
Application #
2887826
Study Section
Surgery, Anesthesiology and Trauma Study Section (SAT)
Program Officer
Prasad, Shiv A
Project Start
1998-06-01
Project End
2003-04-30
Budget Start
1999-05-01
Budget End
2000-04-30
Support Year
2
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Massachusetts General Hospital
Department
Type
DUNS #
City
Boston
State
MA
Country
United States
Zip Code
02199
Jindra, P T; Tripathi, S; Tian, C et al. (2013) Tolerance to MHC class II disparate allografts through genetic modification of bone marrow. Gene Ther 20:478-86
Zhao, X; Boenisch, O; Yeung, M et al. (2012) Critical role of proinflammatory cytokine IL-6 in allograft rejection and tolerance. Am J Transplant 12:90-101
Tian, Chaorui; Yuan, Xueli; Jindra, Peter T et al. (2010) Induction of transplantation tolerance to fully mismatched cardiac allografts by T cell mediated delivery of alloantigen. Clin Immunol 136:174-87
Tian, Chaorui; Yuan, Xueli; Bagley, Jessamyn et al. (2008) Induction of transplantation tolerance by combining non-myeloablative conditioning with delivery of alloantigen by T cells. Clin Immunol 127:130-7
Tian, Chaorui; Ansari, Mohammed Javeed I; Paez-Cortez, Jesus et al. (2007) Induction of robust diabetes resistance and prevention of recurrent type 1 diabetes following islet transplantation by gene therapy. J Immunol 179:6762-9
Tian, C; Bagley, J; Iacomini, J (2007) Homeostatic expansion permits T cells to re-enter the thymus and deliver antigen in a tolerogenic fashion. Am J Transplant 7:1934-41
Bagley, Jessamyn; Tian, Chaorui; Iacomini, John (2007) New approaches to the prevention of organ allograft rejection and tolerance induction. Transplantation 84:S38-41
Tian, C; Bagley, J; Forman, D et al. (2006) Inhibition of CD26 peptidase activity significantly improves engraftment of retrovirally transduced hematopoietic progenitors. Gene Ther 13:652-8
Tian, C; Bagley, J; Iacomini, J (2006) Persistence of antigen is required to maintain transplantation tolerance induced by genetic modification of bone marrow stem cells. Am J Transplant 6:2202-7
Forman, Daron; Kang, Eun-Suk; Tian, Chaorui et al. (2006) Induction of alloreactive CD4 T cell tolerance in molecular chimeras: a possible role for regulatory T cells. J Immunol 176:3410-6

Showing the most recent 10 out of 27 publications